Document And Entity Information us-gaap_DerivativeLossOnDerivative Derivative, Loss on Derivative Expected Dividend Yield Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate bcrx_EmployeeServiceSharebasedCompensationNonvestedAwardsCompensationCostExpectedToBeRecognizedNextYear Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Expected to be Recognized Next Year Employee service share-based compensation nonvested awards compensation cost expected to be recognized next year. bcrx_DebtInstrumentMinimumLibor Debt Instrument, Minimum LIBOR The minimum LIBOR interest that will be added to the basis spread. Note To Financial Statement Details Textual Significant Accounting Policies Note 1 - Significant Accounting Policies and Concentrations of Risk Income tax benefit at federal statutory rate (21% for 2018 and 2017 and 35 % for 2016) Note 2 - Property and Equipment Risk-Free Interest Rate Note 4 - Senior Credit Facility Maturing in one year or less Note 5 - Lease Obligations and Other Contingencies us-gaap_DerivativeGainOnDerivative Derivative, Gain on Derivative Note 7 - Stock-based Compensation Not Designated as Hedging Instrument [Member] Note 8 - Income Taxes Note 11 - Quarterly Financial Information (Unaudited) Note 1 - Significant Accounting Policies and Concentrations of Risk - Fair Value of the Company's Investments by Type (Details) Income Tax Disclosure [Text Block] Note 1 - Significant Accounting Policies and Concentrations of Risk - Scheduled Maturity for the Company's Investments (Details) Unrealized (loss) gain on available for sale investments Note 1 - Significant Accounting Policies and Concentrations of Risk- Summary of Receivables (Details) Hedging Designation [Axis] Note 1 - Significant Accounting Policies and Concentrations of Risk - Accrued Expenses (Details) Hedging Designation [Domain] Expected Volatility Note 1 - Significant Accounting Policies and Concentrations of Risk - Cumulative Effective Adopted Accounting Pronouncement (Details) Note 1 - Significant Accounting Policies and Concentrations of Risk - Summary of Revenues (Details) us-gaap_LiabilitiesCurrent Total current liabilities Schedule of Maturities of Long-term Debt [Table Text Block] Note 2 - Property and Equipment - Property and Equipment (Details) Note 4 - Senior Credit Facility - Scheduled Principal Repayments of the Credit Facility (Details) Note 5 - Lease Obligations and Other Contingencies - Minimum Payments under Operating Lease Obligations (Details) Expected Life (Year) Note 7 - Stock-Based Compensation - Stock-based Compensation Allocation (Details) Note 7 - Stock-based Compensation - Stock Incentive Plan Activities (Details) Note 7 - Stock-based Compensation - Weighted Average Assumptions for Stock Option Awards Granted to Employees and Directors Under the Incentive Plan (Details) Note 7 - Share-Based Compensation - Number of Stock Option Awards Exercisable and their Weighted Average Exercise Price (Details) Note 7 - Share-Based Compensation - Changes in the Number and Weighted-Average Grant-Date Fair Value (Details) Note 8 - Income Taxes - Differences Between the Company's Effective Tax Rate and the Statutory Tax Rate (Details) Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block] Note 8 - Income Taxes - Differences Between the Company's Effective Tax Rate and the Statutory Tax Rate (Details) (Parentheticals) Note 8 - Income Taxes - Reconciliation of Beginning and Ending Amount of Unrecognized Tax Benefits (Details) Note 8 - Income Taxes - Components of Deferred Tax Assets and Liabilities (Details) Note 11 - Quarterly Financial Information (Unaudited) - Schedule of Quarterly Information (Details) Notes To Financial Statements Share-based Compensation, Stock Options, Activity [Table Text Block] Notes To Financial Statements [Abstract] Share-based Compensation, Activity [Table Text Block] us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value Awards available, Restricted stock awards cancelled (in shares) Sales and maturities of investments US Government Agencies Debt Securities [Member] us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod Awards available, Restricted stock awards granted (in shares) Corporate Debt Securities [Member] us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1 Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term us-gaap_CapitalLeaseObligationsCurrent Lease financing obligation us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding and Exercisable [Table Text Block] Other comprehensive income (loss) us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice Weighted average exercise price, ending balance (in dollars per share) us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1 Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value Non-recourse notes payable us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax Reclassification from Accumulated Other Comprehensive Income, Current Period, before Tax Foreign Exchange Contract [Member] us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1 Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value us-gaap_LinesOfCreditCurrent Senior credit facility Stock option awards granted (in dollars per share) Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value Stock option awards vested (in dollars per share) Stock option awards forfeited (in dollars per share) us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue Weighted average grant-date fair value (in dollars per share) Balance December 31, 2018 (in dollars per share) us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares Stock option awards vested (in shares) us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt Purchases of investments Orphan drug credit Represents orphan drug credit. us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares Non-vested stock option awards (in shares) Balance December 31, 2018 (in shares) Financial Instruments [Domain] us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice Weighted average exercise price, beginning balance (in dollars per share) Weighted average exercise price, stock option awards cancelled (in dollars per share) Financial Instrument [Axis] us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Number, Ending Balance Weighted average exercise price, stock option awards granted (in dollars per share) us-gaap_TaxesPayableCurrent Duties and taxes Weighted average exercise price, stock option awards exercised (in dollars per share) Accrued expenses Total accrued expenses us-gaap_EmployeeRelatedLiabilitiesCurrent Compensation and benefits bcrx_MilestonePaymentReceived Milestone Payment Received Represents the amount of milestone payment received. Interest payable Accounts payable us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber Options outstanding, beginning balance (in shares) Options outstanding, ending balance (in shares) Proceeds from sale of property and equipment us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod Options outstanding, stock option awards cancelled (in shares) Credit Facility [Axis] Credit Facility [Domain] us-gaap_OtherAccruedLiabilitiesCurrent Other us-gaap_PolicyTextBlockAbstract Accounting Policies us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee Share-based Compensation Arrangement by Share-based Payment Award, Maximum Number of Shares Per Employee us-gaap_PaymentsToAcquireProductiveAssets Acquisition of property and equipment us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant Awards available, beginning balance (in shares) Awards available, ending balance (in shares) us-gaap_AccruedProfessionalFeesCurrent Professional fees (Decrease) increase in lease financing obligation The increase (decrease) during the period for financing lease obligations. Awards available, plan amendment (in shares) us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1 Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage Seqirus UK Limited [Member] Information pertaining to Seqirus UK Limited. LIABILITIES AND STOCKHOLDERS’ EQUITY Vesting [Axis] Vesting [Domain] Product [Member] us-gaap_Assets Total assets Plan Name [Axis] Plan Name [Domain] Designated for Interest on Notes [Member] Represents the restricted cash designated for interest on the notes. us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized, Total Secured Credit Facility, Third Tranche [Member] Represent the third tranche of a secured credit facility. Secured Credit Facility, Second Tranche [Member] Represents the second tranche of a secured credit facility. Secured Credit Facility, First Tranche [Member] Represents the first tranche of a secured credit facility. Disclosure of Compensation Related Costs, Share-based Payments [Text Block] Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Table Text Block] Equity Award [Domain] Award Date [Axis] Award Date [Domain] Award Type [Axis] Net loss Net loss Net Loss Restricted Stock Units (RSUs) [Member] Performance Shares [Member] Amortization of premium/discount on investments Amount of amortization expense attributable to the discount and premium on investments. Employee Stock Option [Member] Commitments and Contingencies Disclosure [Text Block] us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment Less accumulated depreciation and amortization Property and equipment, net Property and equipment, net Property and equipment Property, Plant and Equipment, Gross, Ending Balance Calculated under Revenue Guidance in Effect before Topic 606 [Member] us-gaap_CapitalLeasesFutureMinimumPaymentsDue Capital Leases, Future Minimum Payments Due, Total Japan, Yen Loss on foreign currency derivative Derivative Instrument [Axis] Derivative Contract [Domain] Investing activities: Estimated Fair Value Total investments Interest payable us-gaap_IncreaseDecreaseInInterestPayableNet us-gaap_IncomeTaxExpenseBenefit Income tax expense Accounts payable and accrued expenses us-gaap_IncreaseDecreaseInAccountsPayable us-gaap_DebtInstrumentTerm Debt Instrument, Term us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount Defined Contribution Plan, Employer Discretionary Contribution Amount All Currencies [Domain] Restricted cash Restricted Cash and Cash Equivalents, Current, Total Cash and cash equivalents Royalty [Member] bcrx_IncomeTaxRateReconciliationAdoptionOfAccountingStandardsUpdateAmount Effect of ASU 2016-09 Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to the effect from the adoption of an accounting standards update. us-gaap_AllocatedShareBasedCompensationExpense Allocated Share-based Compensation Expense, Total Royalty Amendment Flag us-gaap_ComprehensiveIncomeNetOfTax Net comprehensive loss Use of Estimates, Policy [Policy Text Block] bcrx_RevenueRecognitionRoyaltyAndMilestoneRevenueRecognized Revenue Recognition Royalty and Milestone Revenue Recognized Revenue recognition royalty and milestone revenue recognized. Deferred revenue us-gaap_IncreaseDecreaseInContractWithCustomerLiability Common stock, shares outstanding (in shares) Preferred stock, shares outstanding (in shares) bcrx_AverageMaturityPeriodOfHighQualityMarketableSecurities Average Maturity Period of High Quality Marketable Securities Average maturity period of high quality marketable securities. us-gaap_IncreaseDecreaseInDerivativeAssets Change in fair value of foreign currency derivative bcrx_MaturityperiodOfShortTermInvestment Maturity Period of Short Term Investment Maturity period of short term investment. Current Fiscal Year End Date us-gaap_DebtInstrumentBasisSpreadOnVariableRate1 Debt Instrument, Basis Spread on Variable Rate bcrx_DeferredCollaborationExpenseChangesInOperatingAssetsAndLiabilities Deferred collaboration expense Represents deferred collaboration expense. us-gaap_DebtInstrumentInterestRateStatedPercentage Debt Instrument, Interest Rate, Stated Percentage Lease Arrangement, Type [Axis] bcrx_CollaborativeAgreementContractValue Collaborative Agreement Contract Value Represents collaborative agreement contract value. Lease Arrangement, Type [Domain] us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets Prepaid expenses and other assets Document Fiscal Period Focus Document Fiscal Year Focus Mundipharma International Holdings Limited [Member] Information pertaining to Mundipharma International Holdings Limited. Document Period End Date Entity Emerging Growth Company us-gaap_DebtInstrumentFaceAmount Debt Instrument, Face Amount Document Type Entity Small Business bcrx_AverageMaturityForPortfolioInvestments Average Maturity for Portfolio Investments Average maturity for portfolio investments during the period. Entity Shell Company Document Information [Line Items] Document Information [Table] Entity Public Float Entity Filer Category Debt Instrument [Axis] Entity Current Reporting Status Debt Instrument, Name [Domain] Entity Voluntary Filers Entity Well-known Seasoned Issuer London Interbank Offered Rate (LIBOR) [Member] US Department of Health and Human Services [Member] United States department of health and human services. Variable Rate [Domain] AECOM and IRL [Member] AECOM and IRL UAB [Member] UAB us-gaap_IncreaseDecreaseInReceivables Receivables Variable Rate [Axis] us-gaap_ConcentrationRiskPercentage1 Concentration Risk, Percentage us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue Stock-based compensation expense Quarterly Financial Information [Text Block] bcrx_ProceedsFromAwardsForResearchAndDevelopmentContracts Proceeds from awards for Research and Development Contracts Represents proceeds from awards for research and development contracts. Entity Central Index Key Entity Registrant Name Entity [Domain] Legal Entity [Axis] Customer Concentration Risk [Member] bcrx_ExpectedReceivableFromAwardsForResearchAndDevelopmentContracts Expected Receivable From Awards for Research and Development Contracts Represents expected receivable from awards for research and development contracts. Concentration Risk Type [Axis] Concentration Risk Type [Domain] Base Contract [Member] The base contract of ASPR/BARDA to support BCX4430 drug manufacturing. Additional Development Options [Member] The additional development options that can be exercised by the Government. ASPRBARDA Contract [Member] The potential value of the ASPR/BARDA Contract. Entity Common Stock, Shares Outstanding (in shares) Green Cross Corporation [Member] Represents Green Cross Corporation. bcrx_MilestonePaymentMinimum Milestone Payment Minimum Represents milestone payment minimum. bcrx_TransactionCosts Transaction Costs Represents transaction costs associated with royalty monetization. bcrx_InterestReserve Interest Reserve Represents interest reserve established as part of the royalty monetization. bcrx_RequiredForeignCurrencyHedgePerDollar Required Foreign Currency Hedge Per Dollar The Company is required to maintain a foreign currency hedge per dollar under the agreements governing the PhaRMA Notes. bcrx_MilestonePaymentMaximum Milestone Payment Maximum Represents milestone payment maximum. Sales Revenue, Product Line [Member] Royalty Monetization [Member] Represents the royalty monetization transaction. National Institute of Allergy and Infectious Diseases [Member] Represents National Institute of Allergy and Infectious Diseases. us-gaap_IncreaseDecreaseInInventories Inventory Trading Symbol Concentration Risk Benchmark [Axis] Concentration Risk Benchmark [Domain] Employee stock purchase plan sales, shares (in shares) Stock Issued During Period, Shares, Employee Stock Purchase Plans us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd Line of Credit Facility, Interest Rate at Period End Exercise of stock options, shares (in shares) Options outstanding, stock option awards exercised (in shares) us-gaap_TableTextBlock Notes Tables Currency Hedge Agreement [Member] Represents the Currency Hedge Agreement to hedge certain risks associated with changes in the value of the Japanese yen relative to the U.S. dollar. bcrx_MaximumAggregateOfferingPrice Maximum Aggregate Offering Price Represents the maximum aggregate offering price of common stock, preferred stock, depository shares, stock purchase contracts, warrants and units. us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan Employee stock purchase plan sales us-gaap_GainLossOnDispositionOfAssets1 Loss (gain) on disposal of property and equipment bcrx_AnnualLicenseFeeMinimum Annual License Fee Minimum Represent minimum annual license fee. us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised Exercise of stock options bcrx_AnnualLicenseFeeMaximum Annual License Fee Maximum Represents annual maximum license fee. us-gaap_LossOnSaleOfInvestments Loss on Sale of Investments Selling, general and administrative bcrx_NumberOfStockbasedCompensationPlans Number of Stock-based Compensation Plans Represents number of stock based compensation plan. Stock option awards granted (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod Stock option awards forfeited (in shares) Options outstanding, stock option awards granted (in shares) Line of Credit Facility, Lender [Domain] Arrangements and Non-arrangement Transactions [Domain] bcrx_SharebasedCompensationArrangementBySharbasedPaymentAwardAwardsUnvestedPercentage Share-based Compensation Arrangement by Shar-based Payment Award, Awards Unvested, Percentage Represents the percentage of performance awards that remain unvested. Issuance of common stock, shares (in shares) Stock Issued During Period, Shares, New Issues bcrx_AdvanceNoticePeriodForTerminationOfAgreement Advance Notice Period for Termination of Agreement Represents advance notice period for termination of agreement. Lender Name [Axis] bcrx_PercentageOfSalaryToPurchaseCommonStockMaximum Percentage of Salary to Purchase Common Stock, Maximum Represents percentage of salary to purchase common stock maximum. bcrx_PercentageOfCommonStockSharesBeginning Percentage of Common Stock Shares, Beginning Represents percentage of common stock shares beginning. us-gaap_LiabilitiesAndStockholdersEquity Total liabilities and stockholders’ equity bcrx_PercentageOfCommonStockSharesEnding Percentage of Common Stock Shares, Ending Represents percentage of common stock shares ending. Issuance of common stock bcrx_ShareBasedCompensationArrangementBySharbasedPaymentAwardMaximumNumberOfSharesPerEmployeeAmount Shar-based Compensation Arrangement by Shar-based Payment Award, Maximum Number of Shares Per Employee, Amount Represents share-based compensation arrangement by share-based payment award maximum value per employee amount. Accumulated deficit Research and development Accumulated other comprehensive loss Debt Disclosure [Text Block] Cash and Cash Equivalents [Domain] us-gaap_InterestExpense Interest Expense, Total Interest expense us-gaap_InterestExpenseDebt Interest Expense, Debt, Total bcrx_PeriodOfAgreement Period of Agreement Represents period of agreement. Changes in operating assets and liabilities: bcrx_RenewablePeriodOfAgreement Renewable Period of Agreement Represents renewable period of agreement. Amortization of debt issuance costs Amortization of Debt Issuance Costs Restricted Cash and Cash Equivalents [Axis] us-gaap_NotesPayableFairValueDisclosure Notes Payable, Fair Value Disclosure us-gaap_DisclosureTextBlockAbstract Notes to Financial Statements Incentive Plan [Member] Represents Incentive Plan. Employee Stock Purchase Plan [Member] Employee stock purchase plan, (ESPP). Subsequent Event [Member] Royalty Monetization [Text Block] Royalty monetization. us-gaap_OperatingLeaseLiability Operating Lease, Liability, Total Subsequent Event Type [Axis] Subsequent Event Type [Domain] Pension and Other Postretirement Benefits Disclosure [Text Block] Non-employee Directors [Member] Represents non-employee directors of the company. Subsequent Events [Text Block] us-gaap_OperatingLeaseRightOfUseAsset Operating Lease, Right-of-Use Asset Awards available, stock option awards cancelled (in shares) Share based compensation arrangement by share based payment award options forfeitures in period awards available. Maturing after two years Represents debt maturities after two years. Debt Securities, Available-for-sale [Table Text Block] bcrx_PrivatePlacementOfSeniorSecuredNotes Private Placement of Senior Secured Notes Represents private placement of senior secured notes. Other assets Stock-based compensation expense Lessee, Leases [Policy Text Block] Title of Individual [Axis] Relationship to Entity [Domain] Earnings Per Share, Policy [Policy Text Block] bcrx_LongtermInvestmentMaturityMinimum Long-term Investment Maturity, Minimum Represents long term investment maturity minimum. Comprehensive Income, Policy [Policy Text Block] Income Tax, Policy [Policy Text Block] bcrx_MaximumAmountOfCollateralRequiredToPost Maximum Amount of Collateral Required to Post Represents maximum amount of collateral required to post. JPR Royalty Sub LLC [Member] Represents JPR Royalty Sub LLC. PhaRMA Notes Member] Represents PhaRMA notes. Collateral for Credit [Member] Restricted cash and cash equivalents required to maintain as collateral for a letter of credit. Research and Development Expense, Policy [Policy Text Block] RAPIVAB [Member] Represents RAPIVAB product. us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent Investments Depreciation and amortization Depreciation, Depletion and Amortization, Total us-gaap_SharesIssuedPricePerShare Shares Issued, Price Per Share us-gaap_AssetsCurrent Total current assets Share-based Compensation, Option and Incentive Plans Policy [Policy Text Block] Stockholders' Equity Note Disclosure [Text Block] bcrx_MaturityPeriodOfHighQualityMarketablesecurities Maturity Period of High Quality Marketable Securities Represents maturity period of high quality marketable securities. Accrued Interest Represents the amount of accrued interest in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale). Common stock, $0.01 par value; shares authorized — 200,000; shares issued and outstanding — 110,063 at December 31, 2018 and 98,411 at December 31, 2017 Adjustments to reconcile net loss to net cash used in operating activities: Common stock, shares authorized (in shares) Common stock, shares issued (in shares) Certificates of Deposit [Member] Common stock, par value (in dollars per share) Deferred collaboration expense us-gaap_DeferredTaxAssetsValuationAllowance Valuation allowance Range [Domain] Maximum [Member] Available For Sale Securities Debt Maturities Fair Value [Table Text Block] Tabular disclosure of available for sale securities debt maturities fair value. Minimum [Member] Maturing after one year through two years Represents available for sale securities debt maturities after one through two years fair value. Product and Service [Axis] Schedule of Receivables from Collaborations [Table Text Block] Tabular disclosure representing receivables from collaborations. Product and Service [Domain] Range [Axis] us-gaap_OperatingLeasesRentExpenseNet Operating Leases, Rent Expense, Net, Total Shionogi and Co. Ltd [Member] Shionogi & Co. Ltd. Preferred stock, $0.001 par value; shares authorized — 5,000; no shares outstanding CSL Limited [Member Represents CSL Limited which is a company organized under the laws of Australia. us-gaap_DeferredTaxAssetsLiabilitiesNet Net deferred tax assets Preferred stock, shares issued (in shares) Intangible Assets, Finite-Lived, Policy [Policy Text Block] Other Property, Plant and Equipment Disclosure [Text Block] Property, Plant and Equipment [Table Text Block] us-gaap_DeferredTaxAssetsGross Total deferred tax assets Preferred stock, shares authorized (in shares) us-gaap_DeferredIncomeTaxLiabilities Total deferred tax liabilities Inventory Preferred stock, par value (in dollars per share) bcrx_RoyaltyTerm Royalty Term Period of time between the date of the Agreement and its expiration. Revenues Revenues us-gaap_DeferredTaxAssetsDeferredIncome Deferred revenue Fair Value Hierarchy and NAV [Domain] Currency [Axis] Customer [Axis] Customer [Domain] Fair Value, Inputs, Level 2 [Member] Fair Value Hierarchy and NAV [Axis] us-gaap_ProceedsFromLicenseFeesReceived Proceeds from License Fees Received Receivables us-gaap_PropertyPlantAndEquipmentUsefulLife Property, Plant and Equipment, Useful Life bcrx_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodAwardsAvailable Awards available, stock option awards granted (in shares) Represents share based compensation arrangement by share based payment award options grants in period awards available. Operating activities: Revenue Recognition, Policy [Policy Text Block] Statement [Line Items] Furniture and Fixtures [Member] Receivables from collaborations Additional paid-in capital Stock-based compensation Building [Member] Revenues: AOCI Attributable to Parent [Member] Stockholders’ equity: Leasehold Improvements [Member] Investments Property, Plant and Equipment, Policy [Policy Text Block] Property, Plant and Equipment, Type [Axis] Property, Plant and Equipment, Type [Domain] us-gaap_DeferredTaxAssetsOperatingLossCarryforwards Deferred Tax Assets, Operating Loss Carryforwards, Total Research and development credits Description of Company [Policy Text Block] The description of company policy. us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations Cash, cash equivalents and restricted cash at beginning of year Cash, cash equivalents and restricted cash at end of year Net federal and state operating losses Inventory, Policy [Policy Text Block] ASSETS us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect (Decrease) increase in cash, cash equivalents and restricted cash Accounting Standards Update 2016-09 [Member] us-gaap_NetCashProvidedByUsedInFinancingActivities Net cash provided by financing activities: Accrued Expenses [Policy Text Block] Represents accrued expenses policy. Interest Expense and Deferred Financing Costs [Policy Text Block] Represents interest expense and deferred financing costs. Currency Hedge Agreement [Policy Text Block] Represents currency hedge agreement policy. us-gaap_OperatingIncomeLoss Loss from operations us-gaap_NetCashProvidedByUsedInOperatingActivities Net cash used in operating activities: Concentration of Market Risk [Policy Text Block] Represents concentration of market risk policy. Prepaid expenses and other current assets us-gaap_NetCashProvidedByUsedInInvestingActivities Net cash provided by (used in) investing activities: Cost of products sold Counterparty Name [Axis] Counterparty Name [Domain] Accounting Standards Update 2014-09 [Member] Accounting Standards Update 2016-02 [Member] us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued, Total Investment, Policy [Policy Text Block] Type of Adoption [Domain] us-gaap_DeferredTaxLiabilitiesUnrealizedCurrencyTransactionGains Foreign currency derivative us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment Fixed assets Adjustments for New Accounting Pronouncements [Axis] MidCap Financial Services, LLC [Member] Represents MidCap Financial Services, LLC entity. Interest and other income Senior Credit Facility [Member] Represents senior credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing. us-gaap_CostsAndExpenses Total operating expenses Expenses bcrx_AccruedDevelopmentCosts Development costs Represents accrued development costs. us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability Income Tax Expense (Benefit), Continuing Operations, Adjustment of Deferred Tax (Asset) Liability bcrx_AccruedInventoryExpense Inventory Represents the amount of accrued inventory expense. Retained Earnings [Member] Net proceeds from common stock issued under stock-based compensation plans Mundipharma [Member] Information pertaining to Mundipharma. Sale of common stock, net Proceeds from Issuance of Common Stock Initial Application Period Cumulative Effect Transition [Axis] Initial Application Period Cumulative Effect Transition [Domain] Difference between Revenue Guidance in Effect before and after Topic 606 [Member] Additional Paid-in Capital [Member] Common Stock [Member] bcrx_PercentageOfCarryingAmountInExcessOfFairValue1 Percentage of Carrying Amount in Excess of Fair Value Represents the percentage of carrying amount in excess of fair value. Leased Equipment [Member] Information pertaining to leased equipment. Laboratory Equipment [Member] Information pertaining to laboratory equipment. Equity Components [Axis] Equity Component [Domain] us-gaap_LongTermDebt Total Deferred collaboration revenue Deferred revenue Vest Upon Successful Completion of Specific Development Milestones [Member] Represents vesting upon successful completion of specific development milestones. December 2014 [Member] Represents award date of December 2014. Senior credit facility Long-term Line of Credit, Total August 2013 [Member] Represents award date of August 2013. Vest 25% Each Year Until Fully Vested [Member] Represents vest 25% each year until fully vested. State and Local Jurisdiction [Member] Income Tax Authority [Axis] Income Tax Authority [Domain] Disaggregation of Revenue [Table Text Block] Domestic Tax Authority [Member] us-gaap_RepaymentsOfLongTermDebt Repayments of Long-term Debt, Total Office Equipment [Member] Computer Equipment [Member] Cash and Cash Equivalents, Policy [Policy Text Block] Balance Sheet Location [Axis] Balance Sheet Location [Domain] Cash and Cash Equivalents, Restricted Cash and Cash Equivalents, Policy [Policy Text Block] Receivables, Policy [Policy Text Block] Software Development [Member] us-gaap_UnrecognizedTaxBenefits Balance Balance General and Administrative Expense [Member] Accounting Policies [Abstract] Significant Accounting Policies [Text Block] Basis of Accounting, Policy [Policy Text Block] us-gaap_CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption Impact to retained earnings from adoption of ASC 606 Additions to prior period tax positions us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions Reductions to prior period tax provisions Additions to current period tax positions Billing Status, Type [Axis] Research and Development Expense [Member] Receivables Billing Status [Domain] Unbilled Revenues [Member] Billed Revenues [Member] us-gaap_ProceedsFromIssuanceOfSecuredDebt Proceeds from Issuance of Secured Debt Income Statement Location [Axis] Income Statement Location [Domain] Type of Arrangement and Non-arrangement Transactions [Axis] Legal Entity of Counterparty, Type [Axis] Legal Entity Type of Counterparty [Domain] us-gaap_CollateralAlreadyPostedAggregateFairValue Collateral Already Posted, Aggregate Fair Value Collaborative Arrangement Disclosure [Text Block] us-gaap_TaxCreditCarryforwardAmount Tax Credit Carryforward, Amount Research Tax Credit Carryforward [Member] us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount Weighted average shares outstanding (in shares) us-gaap_RepaymentsOfLinesOfCredit Payment of senior credit facility Tax Credit Carryforward [Axis] Tax Credit Carryforward, Name [Domain] Basic and diluted net loss per common share (in dollars per share) Basic and diluted net loss per share (in dollars per share) us-gaap_OperatingLossCarryforwards Operating Loss Carryforwards, Total Proceeds from senior credit facility Statement [Table] Exercise Price Range 01 [Member] Information pertaining to the first exercise range. Scenario [Axis] Statement of Financial Position [Abstract] Scenario, Unspecified [Domain] us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter Thereafter Exercise Price Range 03 [Member] Information pertaining to the third exercise range. us-gaap_OperatingLeasesFutureMinimumPaymentsDue Operating Leases, Future Minimum Payments Due, Total Total minimum payments Exercise Price Range 02 [Member] Information pertaining to the second exercise range. Exercise Price Range 05 [Member] Information pertaining to the fifth exercise range. Exercise Price Range 04 [Member] Information pertaining to the fourth exercise range. us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears 2022 Exercise Price Range 06 [Member] Information pertaining to the sixth exercise range. us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears 2023 Expiration of attribute carryforwards Income tax reconciliation income tax expense benefit expiration of carryforwards. us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears 2020 Statement of Cash Flows [Abstract] us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears 2021 bcrx_UpfrontPaymentsReceivableAmount Upfront Payments Receivable Amount Represents upfront payments receivable. bcrx_PotentialMilestonePaymentsReceivable Potential Milestone Payments Receivable Represents potential milestone payments receivable based on possibility of future event payments. Statement of Stockholders' Equity [Abstract] us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent 2019 Income Statement [Abstract] 2021 us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree 2022 us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour Collaborative and Other Research and Development [Member] Information pertaining to Collaborative and other research and development. Schedule of Accrued Liabilities [Table Text Block] 2019 us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths 2020 us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo Quarterly Financial Information [Table Text Block] Schedule of Future Minimum Rental Payments for Operating Leases [Table Text Block] Schedule of Unrecognized Tax Benefits Roll Forward [Table Text Block] Laboratory Equipment, Office Equipment and Software [Member] Information pertaining to laboratory equipment, office equipment and software. Schedule of Deferred Tax Assets and Liabilities [Table Text Block] Schedule of Effective Income Tax Rate Reconciliation [Table Text Block] us-gaap_GovernmentContractReceivable Government Contract Receivable Birmingham Research Facility [Member] Information pertaining to the Birmingham Research Facility. New Accounting Pronouncements and Changes in Accounting Principles [Text Block] Schedule of New Accounting Pronouncements and Changes in Accounting Principles [Table Text Block] Other Commitments [Axis] Other Commitments [Domain] us-gaap_IncomeTaxReconciliationOtherAdjustments Other Financing activities: Income tax benefit at federal statutory rate, percentage Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent Rate change Change in valuation allowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount us-gaap_EmployeeStockOwnershipPlanESOPWeightedAveragePurchasePriceOfSharesPurchased Employee Stock Ownership Plan (ESOP), Weighted Average Purchase Price of Shares Purchased us-gaap_PaymentsForProceedsFromHedgeInvestingActivities Payments for (Proceeds from) Hedge, Investing Activities, Total Research and Development Arrangement, Contract to Perform for Others, Type [Axis] bcrx_EmployeeServiceShareBasedCompensationNonvestedAwardsCompensationCostExpectedToBeRecognizedYearTwo Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Expected to be Recognized Year Two Employee service share based compensation nonvested awards compensation cost expected to be recognized year two. Research and Development Arrangement, Contract to Perform for Others, Type [Domain] bcrx_EmployeeServiceShareBasedCompensationNonvestedAwardsCompensationCostExpectedToBeRecognizedYearThree Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Expected to be Recognized Year Three Employee service share based compensation nonvested awards compensation cost expected to be recognized year three. bcrx_EmployeeServiceShareBasedCompensationNonvestedAwardsCompensationCostExpectedToBeRecognizedYearFour Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Expected to be Recognized Year Four Employee service share based compensation nonvested awards compensation cost expected to be recognized year four. bcrx_NumberOfMajorCustomers Number of Major Customers Represents the number of major customers accounting for 10% or more of the specified concentration risk benchmark, which includes, but not limited to, sales revenue, accounts receivable, etc. bcrx_ShareBasedCompensationArrangementByShareBasedPaymentAwardFirstVestingPeriodAfterGrantDate Share-based Compensation Arrangement by Share-based Payment Award, First Vesting Period After Grant Date Share based compensation arrangement by share based payment award first vesting period after grant date. Deferred rent Lease financing obligation Lease Financing Obligation, Net of Current Lease Financing obligation as of the balance sheet date. Three Customers [Member] Information pertaining to the three specialty distributors as customers. us-gaap_StockholdersEquity Total stockholders’ equity Balance Balance Permanent items Long Term Liabilities [Member] Represents long term liabilities. Class of Stock [Axis] Outstanding Weighted Average Exercise Price (in dollars per share) us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax Gross Unrealized Losses Outstanding Weighted Average Remaining Life (Year) Gross Unrealized Gains Exercisable Number (in shares) Exercisable Weighted Average Exercise Price (in dollars per share) Upper Exercise Price Range (in dollars per share) Outstanding Number (in shares) Amortized Cost us-gaap_DerivativeForwardExchangeRate1 Derivative, Forward Exchange Rate State and local income taxes net of federal tax benefit Exercise Price Range [Axis] Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Domain] us-gaap_IncomeTaxReconciliationTaxCreditsResearch Research and development tax credits Lower Exercise Price Range (in dollars per share)